Tetramethylpyrazine and paeoniflorin combination(TMP-PF)alleviates atherosclerosis progress by reducing hyperlipemia and inhibiting plaque angiogenesis via the NR4A1/VEGFR2 pathwayOACSTPCD
Atherosclerosis remains a great threat to human health worldwide.Previous studies found that tetramethylpyrazine(TMP)and paeonifl orin(PF)combination(TMP-PF)exerts anti-atherosclerotic effects in vitro.However,whether TMP-PF improves atherosclerosis in vivo needs further exploration.The present study aims to assess the anti-atherosclerotic properties of TMP-PF in ApoE^(-/-)mice and explore the related molecule mechanisms.Results showed that TMP and high-dose TMP-PF decreased serum triglyceride and low-density lipoprotein cholesterol levels,suppressed vascular endothelial growth factor receptor 2(VEGFR2)and nuclear receptor subfamily 4 group A member 1(NR4A1)expression in aortic tissues,inhibited plaque angiogenesis,reduced plaque areas,and alleviated atherosclerosis in ApoE^(-/-)mice.Also,TMP-PF exhibited a better modulation effect than TMP or PF alone.However,NR4A1 agonist abolished the anti-atherosclerotic effects of TMP-PF.In conclusion,TMP-PF was first found to alleviate atherosclerosis progression by reducing hyperlipemia and inhibiting plaque angiogenesis via the NR4A1/VEGFR2 pathway,indicating that TMP-PF had a positive effect on reducing hyperlipemia and attenuating atherosclerosis development.
Rong Yuan;Qiqi Xin;Weili Shi;Yu Miao;Zhengchuan Zhu;Yahui Yuan;Ying Chen;Xiaoning Chen;Sean Xiao Leng;Keji Chen;Weihong Cong;
Cardiovascular Diseases Laboratory,Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing 100091,China National Clinical Research Center for Chinese Medicine Cardiology,Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing 100091,ChinaNational Clinical Research Center for Chinese Medicine Cardiology,Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing 100091,ChinaSchool of Health Economics and Management,Nanjing University of Chinese Medicine,Nanjing 210023,ChinaDepartment of Otolaryngology,Jiangsu Province Hospital of Chinese Medicine,Nanjing 210029,ChinaDivision of Geriatric Medicine and Gerontology,Department of Medicine,Johns Hopkins University School of Medicine,Baltimore 21224,United States
中医学
AtherosclerosisHyperlipemiaAngiogenesisPlaque stabilityChinese medicineTetramethylpyrazinePaeoniflorin
《Food Science and Human Wellness》 2024 (005)
P.2642-2652 / 11
supported by Fundamental Research Funds for the Central Public Welfare Research Institutes(ZZ11-061,ZZ14-YQ-007);the National Natural Science Foundation of China(82004193);CACMS Innovation Fund(CI 2021A00914);Irma and Paul Milstein Program for Senior Health of Milstein Medical Asian American Partnership Foundation。
评论